CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-28 | Shames Richard S. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2018-02-28 | PATEL DINESH V PH D President and CEO | Grant or award | +25,000 | 219,259 | ||
| 2018-02-28 | PATEL DINESH V PH D President and CEO | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-02-28 | O'Neil Thomas P. Chief Financial Officer | Grant or award | +6,000 | 8,858 | ||
| 2018-02-28 | O'Neil Thomas P. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +34,000 | 34,000 | ||
| 2018-02-28 | Liu David Y Chief Scientific Officer | Grant or award | +9,500 | 13,322 | ||
| 2018-02-28 | Liu David Y Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +56,500 | 56,500 | ||
| 2018-01-16 | Liu David Y Chief Scientific Officer | Option exercise | +875 | $1.89 | $2K | 4,697 |
| 2018-01-16 | Liu David Y Chief Scientific Officer | Sale | −875 | $20.00 | $18K | 3,822 |
| 2018-01-16 | Liu David Y Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −875 | 10,600 | ||
| 2017-12-22 | Shames Richard S. Chief Medical Officer | Option exercise | +3,529 | $4.21 | $15K | 3,529 |
| 2017-12-22 | Shames Richard S. Chief Medical Officer | Sale | −3,529 | $20.50 | $72K | 0 |
| 2017-12-22 | Shames Richard S. Chief Medical Officer | Option exercise · Stock Option (right to buy) | −3,529 | 33,273 | ||
| 2017-12-21 | PATEL DINESH V PH D President and CEO | Option exercise | +8,210 | $1.89 | $16K | 198,647 |
| 2017-12-21 | PATEL DINESH V PH D President and CEO | Sale | −8,210 | $19.56 | $161K | 190,437 |
| 2017-12-21 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −8,210 | 44,087 | ||
| 2017-12-20 | PATEL DINESH V PH D President and CEO | Option exercise | +1,790 | $1.89 | $3K | 192,227 |
| 2017-12-20 | PATEL DINESH V PH D President and CEO | Sale | −1,790 | $19.55 | $35K | 190,437 |
| 2017-12-20 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −1,790 | 52,297 | ||
| 2017-12-18 | Liu David Y Chief Scientific Officer | Option exercise | +875 | $1.89 | $2K | 4,697 |
Page 25 of 29 · 580 trades